210 related articles for article (PubMed ID: 28285913)
21. Cyclization-activated prodrugs.
Gomes P; Vale N; Moreira R
Molecules; 2007 Nov; 12(11):2484-506. PubMed ID: 18065953
[TBL] [Abstract][Full Text] [Related]
22. A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs.
Krise JP; Charman WN; Charman SA; Stella VJ
J Pharm Sci; 1999 Sep; 88(9):928-32. PubMed ID: 10479356
[TBL] [Abstract][Full Text] [Related]
23. Self-assembled drug delivery systems. Part 5: self-assemblies of a bolaamphiphilic prodrug containing dual zidovudine.
Jin Y; Qi N; Tong L; Chen D
Int J Pharm; 2010 Feb; 386(1-2):268-74. PubMed ID: 19941945
[TBL] [Abstract][Full Text] [Related]
24. Design strategies in the prodrugs of HIV-1 protease inhibitors to improve the pharmaceutical properties.
Subbaiah MAM; Meanwell NA; Kadow JF
Eur J Med Chem; 2017 Oct; 139():865-883. PubMed ID: 28865281
[TBL] [Abstract][Full Text] [Related]
25. A method for quantitating the intracellular metabolism of AZT amino acid phosphoramidate pronucleotides by capillary high-performance liquid chromatography-electrospray ionization mass spectrometry.
Kim J; Park S; Tretyakova NY; Wagner CR
Mol Pharm; 2005; 2(3):233-41. PubMed ID: 15934784
[TBL] [Abstract][Full Text] [Related]
26. Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles.
Dalpiaz A; Ferraro L; Perrone D; Leo E; Iannuccelli V; Pavan B; Paganetto G; Beggiato S; Scalia S
Mol Pharm; 2014 May; 11(5):1550-61. PubMed ID: 24717116
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of methoxypoly(ethylene glycol) carbonate prodrugs of zidovudine and penetration through human skin in vitro.
N'da DD; Breytenbach JC
J Pharm Pharmacol; 2009 Jun; 61(6):721-31. PubMed ID: 19505362
[TBL] [Abstract][Full Text] [Related]
28. Membrane-permeable Triphosphate Prodrugs of Nucleoside Analogues.
Gollnest T; Dinis de Oliveira T; Rath A; Hauber I; Schols D; Balzarini J; Meier C
Angew Chem Int Ed Engl; 2016 Apr; 55(17):5255-8. PubMed ID: 27008042
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo pharmacokinetic characterization of two novel prodrugs of zidovudine.
Quevedo MA; Briñón MC
Antiviral Res; 2009 Aug; 83(2):103-11. PubMed ID: 19549583
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of bis(t-butyl-SATE)-AZTMP, a bispivaloylthioethyl prodrug for intracellular delivery of zidovudine monophosphate, in mice.
Tan X; Boudinot FD; Chu CK; Egron D; Perigaud C; Gosselin G; Imbach JL
Antivir Chem Chemother; 2000 May; 11(3):203-11. PubMed ID: 10901291
[TBL] [Abstract][Full Text] [Related]
31. Stereospecific chemical and enzymatic stability of phosphoramidate triester prodrugs of d4T in vitro.
Siccardi D; Gumbleton M; Omidi Y; McGuigan C
Eur J Pharm Sci; 2004 May; 22(1):25-31. PubMed ID: 15113580
[TBL] [Abstract][Full Text] [Related]
32. Current prodrug design for drug discovery.
Hsieh PW; Hung CF; Fang JY
Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
[TBL] [Abstract][Full Text] [Related]
33. Dipeptidyl peptidase IV-activated prodrugs of anti-varicella zoster virus bicyclic nucleoside analogues containing different self-cleavage spacer systems.
Diez-Torrubia A; Cabrera S; De Meester I; Camarasa MJ; Balzarini J; Velázquez S
ChemMedChem; 2012 Sep; 7(9):1612-22. PubMed ID: 22887971
[TBL] [Abstract][Full Text] [Related]
34. An improved design of water-soluble propofol prodrugs characterized by rapid onset of action.
Lang BC; Yang J; Wang Y; Luo Y; Kang Y; Liu J; Zhang WS
Anesth Analg; 2014 Apr; 118(4):745-54. PubMed ID: 24651228
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of dually branched 5'-norcarbocyclic adenosine phosphonodiester analogue as a new anti-HIV prodrug.
Oh CH; Liu LJ; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2010 Oct; 29(10):721-33. PubMed ID: 20924954
[TBL] [Abstract][Full Text] [Related]
36. Enhanced delivery of zidovudine through rat and human skin via ester prodrugs.
Seki T; Kawaguchi T; Juni K
Pharm Res; 1990 Sep; 7(9):948-52. PubMed ID: 2235895
[TBL] [Abstract][Full Text] [Related]
37. The Prodrug Approach: A Successful Tool for Improving Drug Solubility.
Jornada DH; dos Santos Fernandes GF; Chiba DE; de Melo TR; dos Santos JL; Chung MC
Molecules; 2015 Dec; 21(1):42. PubMed ID: 26729077
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and bioavailability evaluation of coumarin-based prodrug of meptazinol.
Xie Q; Wang X; Wang X; Jiang Z; Qiu Z
Bioorg Med Chem Lett; 2005 Nov; 15(22):4953-6. PubMed ID: 16154745
[TBL] [Abstract][Full Text] [Related]
39. Is prodrug design an approach to increase water solubility?
Sanches BMA; Ferreira EI
Int J Pharm; 2019 Sep; 568():118498. PubMed ID: 31301465
[TBL] [Abstract][Full Text] [Related]
40. Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries.
Dalpiaz A; Fogagnolo M; Ferraro L; Capuzzo A; Pavan B; Rassu G; Salis A; Giunchedi P; Gavini E
Antiviral Res; 2015 Nov; 123():146-57. PubMed ID: 26427553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
